Datavault AI Inc. (NASDAQ: DVLT) announced an expansion of its definitive licensing agreement with DataMeds AI Inc. (NASDAQ: MEDS), extending the application of its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan, and wellness applications. The amended agreement is designed to support patient-controlled health data access, monetization, and real-world asset tokenization across pharmacy, medical, laboratory, and wearable device environments, leveraging a behavioral healthcare patent portfolio focused on medical logistics, IoT population health, and AI-driven remote patient monitoring.
Under the terms of the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies stated that the agreement accelerates the deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
This expansion is significant because it moves Datavault AI’s blockchain and AI capabilities into the broader healthcare industry, which is increasingly focused on patient data sovereignty and secure data exchange. By integrating its technology into commercial healthcare settings, Datavault AI positions itself to capitalize on the growing demand for decentralized health data management solutions. The collaboration also highlights the potential for tokenizing health-related assets, allowing patients to control and monetize their own data.
Datavault AI’s platform leverages Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization. The company’s technology suite is fully customizable and offers AI- and machine-learning-based automation, third-party integration, detailed analytics, and data marketing automation. With this expanded agreement, Datavault AI aims to bring its innovative solutions to a wider healthcare audience, potentially transforming how patient data is managed and utilized.
For more details, the full press release can be accessed at https://ibn.fm/vBAxH. Information about Datavault AI is available at https://dvlt.ai.
